Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: A meta-analysis of prospective controlled trials

References

• Rinkel GJ. Medical management of patients with aneurysmal subarachnoid haemorrhage. International Journal of Stroke 2008; 3: 193–204
   PubMed Web of Science ®Google Scholar
• Huang J, van Gelder JM. The probability of sudden death from rupture of intracranial aneurysms: A meta-analysis. Neurosurgery 2002; 51: 1101–1105
   PubMed Web of Science ®Google Scholar
• Wong GK, Chan MT, Poon WS, Boet R, Gin T. Magnesium therapy within 48 hours of an aneurysmal subarachnoid haemorrhage: Neuro-panacea. Neurological Research 2006; 28: 431–435
   PubMed Web of Science ®Google Scholar
• Keyrouz SG, Diringer MN. Clinical review: Prevention and therapy of vasospasm in subarachnoid haemorrhage. Critical Care 2007; 4: 211–220
   Google Scholar
• Bederson JB, Connolly ES, Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, Duldner JE, Jr, Harbaugh RE, Patel AB, Rosenwasser RH. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009; 40: 994–1025
   PubMed Web of Science ®Google Scholar
• Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid haemorrhage: A randomized study. Neurosurgery 2006; 58: 1054–1065
   PubMed Web of Science ®Google Scholar
• Stippler M, Crago E, Levy EI, Kerr ME, Yonas H, Horowitz MB, Kassam A. Magnesium infusion for vasospasm prophylaxis after subarachnoid haemorrhage. Journal of Neurosurgery 2006; 105: 723–729
   PubMed Web of Science ®Google Scholar
• Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM. Magnesium sulfate therapy after aneurysmal subarachnoid haemorrhage. Journal of Neurosurgery 2002; 96: 510–514
   PubMed Web of Science ®Google Scholar
• Manno EM. Magnesium sulphate and cerebral vasospasm. Lancet Neurology 2005; 4: 329–330
   PubMed Web of Science ®Google Scholar
• Belfort MA, Anthony J, Saade GR, Allen JC, Jr. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. New England Journal of Medicine 2003; 348: 304–311
   PubMed Web of Science ®Google Scholar
• van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, Rinkel GJ. Magnesium sulfate in aneurysmal subarachnoid haemorrhage: A randomized controlled trial. Stroke 2005; 36: 1011–1015
   PubMed Web of Science ®Google Scholar
• Boet R, Mee E. Magnesium sulfate in the management of patients with fisher grade 3 subarachnoid haemorrhage: A pilot study. Neurosurgery 2000; 47: 602–606
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database of Systematic Reviews 2007; 18: CD000277
   Google Scholar
• Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996; 17: 1–12
   PubMedGoogle Scholar
• Prevedello DM, Cordeiro JG, de Morais AL, Saucedo NS, Jr, Chen IB, Araujo JC. Magnesium sulfate: Role as possible attenuating factor in vasospasm morbidity. Surgical Neurology 2006; 65(Suppl 1)S1:14–S1:20
   Google Scholar
• van Norden AG, van den Bergh WM, Rinkel GJ. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. Journal of Clinical Pharmacy and Therapeutics 2005; 30: 439–442
   PubMed Web of Science ®Google Scholar
• Wong GK, Chan MT, Boet R, Poon WS, Gin T. Intravenous magnesium sulfate after aneurysmal subarachnoid haemorrhage: A prospective randomized pilot study. Journal of Neurosurgical Anesthesiology 2006; 18: 142–148
   PubMed Web of Science ®Google Scholar
• Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E. Magnesium sulfate in the management of patients with aneurysmal subarachnoid haemorrhage: A randomized, placebo-controlled, dose-adapted trial. Surgical Neurology 2008; 69: 33–39
   PubMed Web of Science ®Google Scholar
• Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R. Magnesium and experimental vasospasm. Journal of Neurosurgery 2004; 100: 106–110
   PubMed Web of Science ®Google Scholar
• Chia RY, Hughes RS, Morgan MK. Magnesium: A useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. Journal of Clinical Neuroscience 2002; 9: 279–281
   PubMed Web of Science ®Google Scholar
• Van de Water JM, Van den Bergh WM, Hoff RG, Algra A, Rinkel GJ. Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage. Magnesium Research 2007; 20: 130–135
   PubMed Web of Science ®Google Scholar
• Wong GK, Poon WS. Magnsium and vasospasm. Journal of Neurosurgery 2007; 106: 938–939
   PubMedGoogle Scholar
• Wong GK, Boet R, Poon WS, Chan MT. Trial design in ‘Magnesium sulphate in aneurysmal subarachnoid haemorrhage: A randomized controlled trial’. Stroke 2005; 36: 2530–2531
   PubMed Web of Science ®Google Scholar
• Dorhout Mees SM. Magnesium in aneurysmal subarachnoid haemorrhage (mash ii) phase iii clinical trial mash-ii study group. International Journal of Stroke 2008; 3: 63–65
   PubMed Web of Science ®Google Scholar
• Wong GK, Poon WW. Re: Magnesium sulfate: Role as possible attenuating factor in vasospasm morbidity. Surgical Neurology 2006; 66: 110–111
   PubMedGoogle Scholar